Article info
PDFGenetics
Commentary
Do genomic tests enhance autonomy?
- Correspondence to Eline M Bunnik, Medical Ethics and Philosophy of Medicine, Erasmus MC, dr. Molewaterplein 50, Rotterdam 3015 GE, The Netherlands; e.bunnik{at}erasmusmc.nl
Citation
Do genomic tests enhance autonomy?
Publication history
- Received June 3, 2014
- Accepted June 11, 2014
- First published June 30, 2014.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Direct-to-consumer genomics on the scales of autonomy
- Personal utility is inherent to direct-to-consumer genomic testing
- Personal utility in genomic testing: is there such a thing?
- Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation
- Impact of direct-to-consumer genomic testing at long term follow-up
- A practical guide to interpretation and clinical application of personal genomic screening
- ‘There is a lot of good in knowing, but there is also a lot of downs’: public views on ethical considerations in population genomic screening
- Privacy, autonomy and direct-to-consumer genetic testing: a response to Vayena
- Adopted individuals’ interest in elective genomic testing
- Genomic intensive care: should we perform genome testing in critically ill newborns?